By integrating mechanistic discovery with translational strategy, our findings lay the groundwork for developing ALKBH5‐based diagnostics and therapies, with broader implications for RNA methylation‐targeted interventions in neurodegenerative and metabolic diseases. This evidence concerns the gene ALKBH5 and metabolic disease.